What Is the Best Vancomycin Therapeutic Drug Monitoring Parameter to Assess Efficacy? A Critical Review of Experimental Data and Assessment of the Need for Individual Patient Minimum Inhibitory Concentration Value
Therapeutic drug monitoring is recommended for the use of vancomycin, but a recent widely publicized US medical society consensus statement has changed the suggested optimal method(s) of dose adjustment. Specifically, 24 h area under the curve (AUC<sub>24</sub>)-based monitoring is has b...
Main Author: | Bruce R. Dalton |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/11/3/567 |
Similar Items
-
Evaluation of vancomycin individualized model-based dosing approach in neonates
by: Manal Abouelkheir, et al.
Published: (2023-05-01) -
Clinical Application Value of Pharmacokinetic Parameters of Vancomycin in Children Treated in the Pediatric Intensive Care Unit
by: Bo Zhou, et al.
Published: (2022-06-01) -
Describing vancomycin serum levels in pediatric intensive care unit (ICU) patients: are expected goals being met
by: Talita Muniz Maloni, et al.
Published: (2019-07-01) -
Modeling Approach to Optimizing Dose Regimen of Vancomycin for Chinese Pediatric Patients with Gram-Positive Bacterial Infections
by: Kai Shen, et al.
Published: (2021-04-01) -
Competence Mining of Vancomycin (VAN) in the Management of Infections Due to Bacterial Strains With High VAN Minimum Inhibitory Concentrations (MICs): A Novel Dosing Strategy Based on Pharmacokinetic/Pharmacodynamic Modeling
by: Xiangqing Song, et al.
Published: (2021-04-01)